These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 8846949

  • 21. Resistant-schizophrenia after discontinuation of clozapine: report of two cases.
    Lamia D, Olfa BA, Ines J, Karim T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov 13; 33(8):1553-4. PubMed ID: 19665510
    [No Abstract] [Full Text] [Related]

  • 22. [Atypical pharmacologic characteristics of an antipsychotic drug: clozapine].
    Gosselin O, Ribeyre JM, Kahn JP.
    Encephale; 1997 Sep 13; 23 Spec No 4():2-6. PubMed ID: 9417400
    [Abstract] [Full Text] [Related]

  • 23. New vs. old antipsychotics: the Texas experience.
    Reid WH.
    J Clin Psychiatry; 1999 Sep 13; 60 Suppl 1():23-5; discussion 28-30. PubMed ID: 10037167
    [Abstract] [Full Text] [Related]

  • 24. Clozapine alone versus clozapine and risperidone for refractory schizophrenia.
    Gerson SL.
    N Engl J Med; 2006 Apr 27; 354(17):1846-8; author reply 1846-8. PubMed ID: 16642587
    [No Abstract] [Full Text] [Related]

  • 25. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients.
    Meged S, Stein D, Sitrota P, Melamed Y, Elizur A, Shmuelian I, Gazit E.
    Int Clin Psychopharmacol; 1999 Sep 27; 14(5):305-12. PubMed ID: 10529073
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Ogilvie Syndrome induced by clozapine].
    de Bruin GJ, Bac DJ, van Puijenbroek EP, van der Klooster JM.
    Ned Tijdschr Geneeskd; 2009 Sep 27; 153():B437. PubMed ID: 20051163
    [Abstract] [Full Text] [Related]

  • 32. [Clozapine screening: white bloodcell counts no longer sufficient].
    Cohen D, Clozapinepluswerkgroep.
    Tijdschr Psychiatr; 2010 Sep 27; 52(11):785-90. PubMed ID: 21064021
    [Abstract] [Full Text] [Related]

  • 33. [Eosinophilic colitis caused by clozapine].
    de Raad AW, Siegersma NC, Clahsen PC, Hagestein-de Bruijn C.
    Ned Tijdschr Geneeskd; 2011 Sep 27; 155(36):A3620. PubMed ID: 21914234
    [Abstract] [Full Text] [Related]

  • 34. Salivary flow rate in patients with schizophrenia on clozapine.
    Praharaj SK, Jana AK, Goswami K, Das PR, Goyal N, Sinha VK.
    Clin Neuropharmacol; 2010 Jul 27; 33(4):176-8. PubMed ID: 20661023
    [Abstract] [Full Text] [Related]

  • 35. Impact of complete blood count sampling time change on white blood cell and absolute neutrophil count values in clozapine recipients.
    McKee JR, Wall T, Owensby J.
    Clin Schizophr Relat Psychoses; 2011 Apr 27; 5(1):26-32. PubMed ID: 21459736
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pharmacologic advances in the treatment of schizophrenia.
    Keith SJ.
    N Engl J Med; 1997 Sep 18; 337(12):851-2. PubMed ID: 9295245
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.